Skip to main content

Table 2 Demographics, clinical and treatment data of GBM patients (univariate analyses)

From: The immunohistochemical landscape of the VEGF family and its receptors in glioblastomas

  N (%) HR CI 95% P
Gender
 Female 26 (37.1) 1   
 Male 44 (62.9) 1.26 (0.75–2.11) 0.39
Age (yr)
 < 50 15 (21.4) 1   
 ≥ 50 55 (78.6) 1.61 (0.89–2.92) 0.12
KPS (%)
 < 70 20 (28.6) 1   
> 70 43 (61.4) 0.51 (0.29–0.89) 0.02
 NA 7 (10.0)    
Neurosurgery (extent of resection)
 Biopsy 4 (5.7) 1   
 Partial 41 (58.6) 0.42 (0.13–1.41) 0.16
 Radical 25 (35.7) 0.24 (0.17–0.57) 0.02
Adjuvant treatment
 Best supportive care 21 (30.0) 1   
 Only RT 16 (22.9) 0.52 (0.26–1.05) 0.07
 RT and sequencing chemotherapy 20 (28.6) 0.32 (0.17–0.62) 0.001
 RT concurrent with chemotherapy 13 (18.6) 0.30 (0.14–0.63) 0.002
  1. NA Not available